Clinical Trial Update: Cardiox Liver Function Test Pivotal Trial [Phase 3]

View source ↗

Summary

Cardiox Corporation reports that its Phase 3 pivotal trial for the Cardiox Liver Function Test has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Failure
• Liver Failure

Drugs mentioned

• Cardiox Liver Function Test

Snippet

Sponsor: Cardiox Corporation | Conditions: Hepatic Failure, Liver Failure | Phase 3 | Status: WITHDRAWN